Back to search results

Smartphone Intervention for Mental Health in Breast Cancer Survivors

This study is testing a smartphone app called "Digital Micro-Interventions" to help women who have had breast cancer and are experiencing symptoms of anxiety or depression. These digital tools are designed to be brief and target specific ways of thinking and behaving that affect mental health. The researchers want to see if using this app can reduce anxiety and depression symptoms. You might be able to join if you are a woman aged 18 or older, were diagnosed with Stage I, II, or III breast cancer within the last 0-5 years, and have elevated symptoms of depression or anxiety. The study aims to enroll 44 participants.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 44 women.
What's involved
You would use the Digital Micro-Interventions app for 8 weeks. Your anxiety and depression symptoms will be measured at the beginning and after 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
Your anxiety and depression symptoms will be measured at the end of the 8-week intervention period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07665346

A Pre-post Pilot of a Smartphone Intervention

Not Yet Recruiting
NAAges 18+InterventionalTreatment
University of Virginia
~44 participants
Updated 2026-06-24 on ClinicalTrials.gov
What's tested:Digital Micro-Interventions

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Anxiety Symptoms
Measured over Baseline
+3 more outcomes measured

Conditions

Mental Health Issue
Breast Cancer

Explore related trials

AnxietyBreast CarcinomaDepression

Where it's being run

1 sites across 1 states
Virginia1

Who to contact

Philip Chow, PhD
[email protected]
434-924-8082
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

age = 18 years
0-5 years post-diagnosis of Stage I, II, or III female breast cancer
elevated symptoms of depression and/or anxiety as measured by the PHQ-8 (score \> 9) or GAD-7 (score \> 7).

Exclusion

receiving individual (1 on 1) treatment for depression and/or anxiety to avoid treatment interference (note, individuals will be permitted to enroll if they are taking antidepressant medication and have not had an appointment to adjust the dosage over the past 2 weeks)
active suicidal ideation during the enrollment/screening call based on a trained staff member orally administering the suicidality item from the PHQ-9 to individuals on the phone ("In the last 2 weeks, have you had thoughts that you would be better off dead, or thoughts of hurting yourself in some way?"). If an individual responds in any way other than "not at all" based on the available response options (i.e., either "several days", "more than half the days", or "nearly every day"), or if they mention having suicidal ideation or thoughts of death during the enrollment/screening call, the Pitt-Optimum risk assessment tool will be administered. Only participants deemed low risk may proceed in enrollment; all will be given additional resources
do not have an app-compatible phone
cannot read and speak English (intervention and measures only available in English).

What this trial measures

  • Anxiety SymptomsBaseline

    7 item scale that measures anxiety symptoms on a continuous scale. Scores range from 0-21, with a higher score indicating greater severity of symptoms of anxiety.

  • Anxiety SymptomsPost 8-week Intervention

    7 item scale that measures anxiety symptoms on a continuous scale. Scores range from 0-21, with a higher score indicating greater severity of symptoms of anxiety.

  • Depression symptomsBaseline

    8 item scale that measures depression symptoms on a continuous scale. Scores range from 0-24, with a higher score indicating greater severity of symptoms of depression.

  • Depression symptomsPost 8-week Intervention

    8 item scale that measures depression symptoms on a continuous scale. Scores range from 0-24, with a higher score indicating greater severity of symptoms of depression.